SEC Form 4 · accession 0001179110-18-007236
MOMENTA PHARMACEUTICALS INC · MNTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Young Kwon
Officer — SVP, Corporate Development
Period of report
May 17, 2018
Accepted (ET)
May 21, 2018 · 4:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235010
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 17, 2018 | M | 5,000 | $13.26 | A | 146,975 | D | |
| Common Stock | May 17, 2018 | S | 5,000 | $22.90 | D | 141,975 | D | |
| Common Stock | May 17, 2018 | M | 2,000 | $15.44 | A | 143,975 | D | |
| Common Stock | May 17, 2018 | S | 2,000 | $22.90 | D | 141,975 | D | |
| Common Stock | May 17, 2018 | M | 2,000 | $12.58 | A | 143,975 | D | |
| Common Stock | May 17, 2018 | S | 2,000 | $22.90 | D | 141,975 | D | |
| Common Stock | May 17, 2018 | M | 3,000 | $17.96 | A | 144,975 | D | |
| Common Stock | May 17, 2018 | S | 3,000 | $22.90 | D | 141,975 | D | |
| Common Stock | May 17, 2018 | M | 2,000 | $13.02 | A | 143,975 | D | |
| Common Stock | May 17, 2018 | S | 2,000 | $22.90 | D | 141,975 | D | |
| Common Stock | May 17, 2018 | S | 787 | $22.90 | D | 141,188 | D | |
| Common Stock | May 17, 2018 | S | 213 | $22.90 | D | 140,975 | D | |
| Common Stock | May 21, 2018 | S | 351 | $23.40 | D | 140,624 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option(Right to Buy) | $13.26 | May 17, 2018 | M | 5,000 | D | Feb 22, 2015 | Feb 22, 2021 | Common Stock | 5,000 | 47,000 | D |
| Stock Option(Right to Buy) | $15.44 | May 17, 2018 | M | 2,000 | D | Feb 14, 2016 | Feb 14, 2022 | Common Stock | 2,000 | 24,000 | D |
| Stock Option(Right to Buy) | $12.58 | May 17, 2018 | M | 2,000 | D | Feb 19, 2017 | Feb 19, 2023 | Common Stock | 2,000 | 24,800 | D |
| Stock Option(Right to Buy) | $17.96 | May 17, 2018 | M | 3,000 | D | Feb 18, 2018 | Feb 18, 2024 | Common Stock | 3,000 | 28,986 | D |
| Stock Option(Right to Buy) | $13.02 | May 17, 2018 | M | 2,000 | D | May 18, 2018 | Feb 18, 2025 | Common Stock | 2,000 | 31,725 | D |
Explanation of responses
- F1This transaction was effected pursuant to a Rule 10b5-1 trading plan.